-
Exosomal Egr2 Protects Neurons via the RNF8/DAPK1 Axis
2026-09-15
The reference study identifies BMSC-derived exosomal Egr2 as a regulator of neuronal injury after oxygen-glucose deprivation/reoxygenation, linking transcriptional activation of RNF8 with ubiquitination-related control of DAPK1. Its integrated use of exosome characterization, promoter assays, rescue experiments, and co-immunoprecipitation provides a mechanistic framework for studying paracrine neuroprotection, while the in vitro design leaves important questions about in vivo transferability.
-
Diphenyleneiodonium chloride in ROS Assays
2026-09-14
Diphenyleneiodonium chloride is a versatile redox perturbation tool for separating oxidase-dependent ROS production from cAMP-linked signaling. This practical guide connects DPI workflows to citrus pathogen-resistance research, cell-based pathway assays, and troubleshooting strategies that limit off-target interpretation.
-
miR-196a Drives EAC via the MYC/TERT/NFκB Axis
2026-09-14
A 2025 Molecular Oncology study identifies miR-196a as an active driver of aggressive esophageal adenocarcinoma behavior rather than merely a progression marker. By connecting NFKBIA, VCP, c-MYC, TERT, and NFκB signaling to epithelial-to-mesenchymal transition and motility, the work provides a mechanistic framework for testing pathway dependence in cancer research.
-
Western Secondary Antibody Dilution Buffer Guide
2026-09-13
Learn how to standardize secondary-antibody handling for cleaner, more reproducible Western blots in macrophage and atherosclerosis research. This guide connects practical reagent management with the NHE1/Olfr2 mechanism and shows when reuse, controls, and troubleshooting can improve assay efficiency.
-
Pentoxifylline in Leishmania and HTLV-1 Infections
2026-09-12
The 2008 reference paper synthesized mechanistic, patient-sample, and clinical evidence that Pentoxifylline can reduce pathological T-cell and cytokine responses in HTLV-1-associated myelopathy and leishmaniasis. Its central contribution was to frame cytokine down-modulation as a potential way to limit immune-mediated tissue injury without treating Pentoxifylline as a direct antimicrobial agent.
-
GSK-923295: Reliable CENP-E Assay Design
2026-09-11
Learn how GSK-923295, SKU A3450, can clarify mitotic arrest, chromosome-alignment defects, and growth-inhibition data in cell-based assays. This scenario-driven guide covers mechanism, controls, formulation, interpretation, and practical product-selection criteria for cancer research.
-
LPS Protection of Macrophages via System Xc− and ABCC1
2026-09-11
Qiao and colleagues show that lipopolysaccharide selectively protects macrophages from antitumor drug-induced injury without producing comparable protection in tumor cells. Their mechanistic data connect this phenotype to system Xc−-dependent glutathione maintenance and ABCC1-associated drug handling, providing a framework for studying immune-cell resilience during chemotherapy.
-
Gramine, CUL3–MTDH, and Ferroptosis in TNBC
2026-09-10
The reference study identifies Gramine as a natural indole alkaloid that suppresses triple-negative breast cancer by engaging the CUL3–MTDH regulatory axis and promoting ferroptosis. Its combined chemical-screening, target-engagement, rescue, and xenograft experiments provide a mechanistic framework for using Gramine in ferroptosis and cancer biology research.
-
Nadolol (SQ-11725) Experimental Workflow Guide
2026-09-10
Build more interpretable cardiovascular assays with Nadolol (SQ-11725) by pairing beta-adrenergic readouts with transporter-aware exposure controls. This workflow uses practical concentration, timing, storage, and troubleshooting guidance for hypertension research, angina pectoris studies, and vascular headache research.
-
Dihydroethidium (DHE) for Superoxide Assays
2026-09-09
Build a practical Dihydroethidium workflow for live-cell superoxide detection, from DMSO stock preparation to flow cytometry and microscopy. The approach translates a 2025 doxorubicin cardiotoxicity study into assay choices for oxidative stress, apoptosis, and cardiovascular disease research while highlighting specificity limits and troubleshooting controls.
-
Sisomicin Activity Against Clinical Isolates
2026-09-09
This reference study established a comparative in vitro profile for sisomicin across a broad panel of clinical gram-negative and gram-positive isolates. Its MIC data showed strong activity against most tested organisms, while the resistance comparisons demonstrated both the promise of sisomicin and the limits of inferring activity against aminoglycoside-resistant strains.
-
TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis
2026-09-08
Zhou and colleagues identify TSPAN18 as a stabilizer of STIM1 that prevents TRIM32-mediated ubiquitination and degradation, thereby enhancing store-operated calcium entry and prostate cancer bone metastasis. The study provides a mechanistic framework for connecting protein stability, calcium signaling, metastatic behavior, and clinical outcome while defining testable directions for prostate cancer research.
-
3-Methyladenine for Reproducible Autophagy Assays
2026-09-08
This scenario-driven guide explains how 3-Methyladenine (SKU A8353) can improve the interpretation of cell viability, proliferation, migration, and autophagy experiments. It covers mechanism, controls, preparation, concentration selection, storage, and practical vendor-selection criteria for reproducible laboratory workflows.
-
gamma-Glu-Cys (γ-Glu-Cys) Workflow Guide
2026-09-07
This guide explains how to use gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, as a defined substrate and intermediate in glutathione synthetase enzyme assay workflows and related peptide studies. It covers solution preparation, storage, controls, and evidence boundaries; the material is for scientific research only and should not be used for diagnostic, clinical, or medical applications.
-
Gramine, CUL3–MTDH Ubiquitination, and TNBC
2026-09-07
A 2026 study identifies Gramine as a selective ferroptosis inducer in triple-negative breast cancer and links its activity to direct modulation of CUL3 and MTDH ubiquitination. The work combines chemical-probe profiling, target-engagement assays, genetic perturbation, ferroptosis rescue experiments, and mouse models to define a mechanistic framework for TNBC research.